TapImmune Inc. Announces $2 Million Registered Direct Offering
PharmiWeb.com (press release) In addition the Company will issue to the investor warrants to purchase up to 1886793 shares of common stock. The warrants have an exercise price of $1.17 per share and are exercisable for five years following issuance. The offering is expected to … |